J05AP53 ombitasvir, paritaprevir and ritonavir
ATC group of level 5 – chemical substance · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 1 medicine in this group.
- 1 no longer supplied or not available
Active substance: Ritonavir – all medicines with this substance, also in combinations.
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
- J05AP Antivirals for treatment of HCV infections 25 medicines
- J05AP53 ombitasvir, paritaprevir and ritonavir 1 medicine
- J05AP Antivirals for treatment of HCV infections 25 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Viekirax SPC no longer supplied | – |
Other groups of the same level
- J05AP01 ribavirin 6 medicines
- J05AP07 daclatasvir 1 medicine
- J05AP08 sofosbuvir 4 medicines
- J05AP09 dasabuvir 1 medicine
- J05AP51 sofosbuvir and ledipasvir 4 medicines
- J05AP54 elbasvir and grazoprevir 2 medicines
- J05AP55 sofosbuvir and velpatasvir 4 medicines
- J05AP57 glecaprevir and pibrentasvir 2 medicines
Other names of the ATC group
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AP53
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.